🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,57 USD

Máx. histórico

178,74

2144 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,17%

Rango 52 semanas

14,68 – 24,68

Variación hoy

-7,48%

Cierre anterior

18,99

Rango de hoy

17,44 – 18,92

Volumen hoy

1.859.162

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 20 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
01/05/2019 116,80 117,96 113,06 115,60 -1,15% 4,20% 970.000
30/04/2019 122,34 125,13 115,01 116,94 -4,59% 8,27% 1.736.500
29/04/2019 121,74 124,35 121,22 122,56 +1,12% 2,57% 1.145.100
26/04/2019 120,02 121,99 117,63 121,20 +0,82% 3,63% 499.600
25/04/2019 118,00 120,56 116,75 120,22 +1,74% 3,23% 449.500
24/04/2019 118,20 119,64 115,51 118,16 +0,06% 3,49% 637.700
23/04/2019 113,98 118,35 112,54 118,09 +3,78% 5,10% 1.422.100
22/04/2019 116,19 117,39 112,36 113,79 -2,44% 4,33% 1.198.100
18/04/2019 119,01 120,17 116,26 116,64 -1,76% 3,29% 2.391.600
17/04/2019 122,12 124,35 117,63 118,73 -2,35% 5,50% 1.605.200
16/04/2019 120,13 125,13 120,00 121,59 +1,52% 4,27% 909.600
15/04/2019 117,63 120,15 116,84 119,77 +1,94% 2,81% 1.023.900
12/04/2019 121,81 122,76 117,48 117,49 -2,59% 4,33% 1.178.900
11/04/2019 126,90 127,00 120,27 120,62 -4,73% 5,30% 866.300
10/04/2019 124,50 127,34 123,53 126,61 +2,10% 3,06% 607.200
09/04/2019 123,17 126,25 122,69 124,01 +0,06% 2,89% 571.600
08/04/2019 124,69 124,94 121,64 123,94 -0,75% 2,65% 656.600
05/04/2019 121,27 125,50 121,27 124,88 +3,18% 3,49% 1.096.600
04/04/2019 122,74 123,27 119,27 121,03 -1,34% 3,26% 925.100
03/04/2019 122,81 124,41 121,65 122,68 -0,02% 2,25% 729.600
02/04/2019 118,00 124,00 117,19 122,70 +3,88% 5,77% 1.349.000
01/04/2019 120,18 121,03 116,80 118,12 -0,90% 3,52% 1.139.000
29/03/2019 119,16 120,00 117,28 119,19 +0,43% 2,28% 1.581.500
28/03/2019 119,63 120,05 116,20 118,68 +1,80% 3,22% 1.325.300
27/03/2019 121,62 122,33 115,65 116,58 -4,44% 5,49% 1.414.800
26/03/2019 119,65 122,75 118,50 122,00 +2,59% 3,55% 1.490.500
25/03/2019 126,02 126,36 113,51 118,92 -2,73% 10,20% 2.731.900
22/03/2019 125,61 127,35 122,25 122,26 -3,47% 4,06% 1.216.400
21/03/2019 127,50 131,99 124,86 126,66 +2,27% 5,59% 1.894.700
20/03/2019 125,85 126,17 121,61 123,85 -2,07% 3,62% 1.349.300